Valério Berdini

Virtual Screening Using Protein−Ligand Docking:  Avoiding Artificial Enrichment

Marcel L. Verdonk, Valério Berdini, Michael J. Hartshorn et al. · Journal of Chemical Information and Computer Sciences · 2004 · 378 citations

Pharmacy, Medicinal Chemistry, Computational Medicinal Chemistry +14

Identification of <i>N</i>-(4-Piperidinyl)-4-(2,6-dichlorobenzoylamino)-1<i>H</i>-pyrazole-3-carboxamide (AT7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment-Based X-Ray Crystallography and Structure Based Drug Design

Paul G. Wyatt, Andrew Woodhead, Valério Berdini et al. · Journal of Medicinal Chemistry · 2008 · 341 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Fragment-Based Discovery of the Pyrazol-4-yl Urea (AT9283), a Multitargeted Kinase Inhibitor with Potent Aurora Kinase Activity

Steven Howard, Valério Berdini, John A. Boulstridge et al. · Journal of Medicinal Chemistry · 2008 · 331 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +14

Identification of Inhibitors of Protein Kinase B Using Fragment-Based Lead Discovery

Gordon Saxty, Steven J. Woodhead, Valério Berdini et al. · Journal of Medicinal Chemistry · 2007 · 139 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

2-Arylpropionic CXC Chemokine Receptor 1 (CXCR1) Ligands as Novel Noncompetitive CXCL8 Inhibitors

Marcello Allegretti, Riccardo Bertini, Maria Candida Cesta et al. · Journal of Medicinal Chemistry · 2005 · 127 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17